Wide Ranks

BIAF

bioAffinity Technologies, Inc.

1.17

Top Statistics
Market Cap 18 M Forward PE -1.77 Revenue Growth 12047.40 %
Current Ratio 1.15 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -119.41 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.30 Enterprise / Revenue 2.52 Price To Sales Trailing12 Months 2.49
Profitability
Profit Margins -119.41 % Operating Margins -87.08 %
Balance Sheet
Total Cash 801311 Total Cash Per Share 0.0600 Total Debt 1 M
Total Debt To Equity 40.20 Current Ratio 1.15 Book Value Per Share 0.5170
All Measures
Short Ratio 143.00 % Message Board Id finmb_423045573 Shares Short Prior Month 396176
Return On Equity -1.52 City San Antonio Uuid eaab05b5-2e95-3da9-8f74-9b1e2252e144
Previous Close 1.19 First Trade Date Epoch Utc 1 B Book Value 0.5170
Beta 3.12 Total Debt 1 M Volume 108718
Price To Book 2.26 Fifty Two Week Low 1.03 Total Cash Per Share 0.0600
Total Revenue 7 M Shares Short Previous Month Date 1 B Target Median Price 6.00
Max Age 86400 Recommendation Mean 2.00 Sand P52 Week Change 0.3133
Operating Margins -87.08 % Target Mean Price 6.00 Net Income To Common -8736142
Short Percent Of Float 0.0285 Implied Shares Outstanding 15 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 107270 Average Volume10days 107270
Total Cash 801311 Next Fiscal Year End 1 B Revenue Per Share 0.7440
Held Percent Insiders 0.2955 Ebitda Margins -109.82 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 1.19
Target Low Price 6.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.60
Open 1.23 Free Cashflow -4287389 State TX
Dividend Yield 0.00 % Return On Assets -0.6978 Time Zone Short Name EST
Trailing Eps -0.8000 Day Low 1.03 Address1 22211 West Interstate 10
Shares Outstanding 15 M Price Hint 4 Target High Price 6.00
Website https://www.bioaffinitytech.com 52 Week Change -0.2952 Average Volume 125664
Forward Eps -0.6000 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 103.00 % Is_sp_500 False Regular Market Day High 1.23
Profit Margins -119.41 % Debt To Equity 40.20 Fifty Two Week High 3.62
Day High 1.23 Shares Short 271434 Regular Market Open 1.23
Industry Key diagnostics-research Earnings Growth 0.00 % Enterprise To Revenue 2.52
Revenue Growth 12047.40 % Shares Percent Shares Out 0.0175 Operating Cashflow -7027216
Currency USD Time Zone Full Name America/New_York Market Cap 18 M
Is_nasdaq_100 False Zip 78257 Quote Type EQUITY
Industry Diagnostics & Research Long Name bioAffinity Technologies, Inc. Regular Market Day Low 1.03
Held Percent Institutions 0.0303 Current Price 1.17 Address2 Suite 1206
Enterprise To Ebitda -2.30 Financial Currency USD Current Ratio 1.15
Gross Margins 35.47 % Industry Disp Diagnostics & Research Number Of Analyst Opinions 1
Country United States Float Shares 8 M Two Hundred Day Average 1.98
Enterprise Value 18 M Price To Sales Trailing12 Months 2.49 Forward PE -1.77
Regular Market Volume 108718 Ebitda -8034549 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung.

It offers CyPath lung, a diagnostic test, for early detection of lung cancer.

The company was incorporated in 2014 and is based in San Antonio, Texas.